CONCORD BIOTECH
Back to Balance Sheet
|
CONCORD BIOTECH Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹184 Cr | ₹142 Cr | ₹192 Cr | ₹344 Cr | ₹236 Cr |
What is the latest Total Current Liabilities ratio of CONCORD BIOTECH ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹184 Cr |
| Mar2024 | ₹142 Cr |
| Mar2023 | ₹192 Cr |
| Mar2022 | ₹344 Cr |
| Mar2021 | ₹236 Cr |
How is Total Current Liabilities of CONCORD BIOTECH Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹184 Cr | 29.48 | |
| Mar2024 | ₹142 Cr | -25.90 | |
| Mar2023 | ₹192 Cr | -44.27 | |
| Mar2022 | ₹344 Cr | 45.91 | |
| Mar2021 | ₹236 Cr | - | |
Compare Total Current Liabilities of peers of CONCORD BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CONCORD BIOTECH | ₹11,309.9 Cr | 1.8% | -8.4% | -35.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,937.0 Cr | 1.2% | -7% | 2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,359.0 Cr | 1.8% | 2.7% | 17% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,431.0 Cr | 0.5% | -4.8% | 32.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,114.0 Cr | 0.3% | -4.5% | 11.5% | Stock Analytics | |
| CIPLA | ₹100,028.0 Cr | 0.7% | -5.8% | -13.1% | Stock Analytics | |
CONCORD BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CONCORD BIOTECH | 1.8% |
-8.4% |
-35.3% |
| SENSEX | 2.4% |
3.2% |
5.8% |
You may also like the below Video Courses